Vedran Radonić

Vedran Radonić

Auto-generated profile, based on publicly available information

Vedran Radonić

Department of Cardiology, University Hospital Merkur

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2025 in Premier Journal of Cardiology
Verified
Journal Article
Open access
VRVedran Radonić
Vedran Radonić
Percutaneous transluminal coronary angioplasty with drug-coated balloons (DCBs) is the modality of coronary artery revascularization with local application of antiproliferative agents, paclitaxel or sirolimus. It has become an appealing alternative to drug-eluting stents (DESs) due to intervention simplification, absence of permanent metallic mesh implantation, preserved vasomotion, and shorter duration of dual antiplatelet therapy because of reduced risk of acute thrombosis. Numerous studies have assessed DCB safety and efficacy for various aspects of coronary artery disease (CAD) for in-stent restenosis (ISR) and de novo CAD, while interventional cardiologists worldwide report good results with DCB in everyday practice. However, data is not robust enough to recommend DCB according to the European Society of Cardiology guidelines, except for the ISR of bare-metal stents (BMSs). At the same time, the United States Food and Drug Administration approved the DCB usage for ISR of both BMS and DES in March 2024. Further studies are underway to increase the body of evidence, and new technologies, including DCB with combined paclitaxel and sirolimus, are developing.

29 August 2025 in Premier Journal of Cardiology
Verified
Journal Article
Open access
VRVedran Radonić
Vedran Radonić
This article is a narrative review based on literature search primarily on PubMed about connections of physical activity and cardiovascular health. Moderate physical activity increases life expectancy and provides numerous cardiovascular benefits. It reduces the risk of atherosclerosis, atrial fibrillation (AF) incidence, arterial hypertension, hyperlipidemia, and diabetes. Accordingly, the World Health Organization guidelines recommend a minimum of 150 min of moderate physical activity or 75 min of vigorous physical activity per week, or a combination of the intensities of appropriate duration, for adults aged 18–64 years. For additional beneficial health effects, 300 or more minutes of moderate physical activity or 150 or more minutes of vigorous physical activity, with the option of combining training intensities, are recommended. On the other hand, evidence on vigorous physical activity is less clear, and evidence is more conflicting. There is a hypothesis that intense exercise may harm the cardiovascular system, causing enlargement of all heart chambers, myocardial fibrosis (primarily of the right ventricle), and increasing the risk, of coronary artery calcification, AF, and sudden cardiac death. Despite recent advancements, there is no firm evidence on the clinical significance of these conditions. Hence, current recommendations do not advise specific exercise intensity limits. The most important sports medicine task is identifying the athletes with an unacceptably high risk of triggering sudden cardiac death during sports activity and advising them with appropriate recommendations.

2 June 2026 in Medicina
Verified
Journal Article
Open access
PDF file
MSMira Stipcevic
Mira Stipcevic
IJIvana Jurin
Ivana Jurin
Marijana Knežević PravečekMarijana Knežević Praveček
Marijana Knežević Praveček
KSKristina Selthofer-Relatić
Kristina Selthofer-Relatić
LDLaura Dražić
Laura Dražić
MTMatias Trbusic
Matias Trbusic
Background and Objectives: Younger and middle-aged women may continue to describe psychological and psychosocial burden years after myocardial infarction (MI), yet multicenter real-world data remain limited on what women retrospectively report during long-term follow-up. This study examined such reports in younger and middle-aged women with prior MI while explicitly accounting for delayed, heterogeneous follow-up timing and the non-standardized nature of symptom ascertainment. Materials and Methods: We performed a cross-sectional analysis within a Croatian multicenter cohort of 957 women younger than 60 years hospitalized with STEMI or NSTEMI between 1 February 2020 and 28 February 2025. Psychological information was collected retrospectively during routine follow-up; the formal PHQ-4 instrument was not administered. A study-specific four-item summary informed by PHQ-4 content was described, and exploratory multivariable analyses modelled this summary as a continuous variable. Descriptive timing-stratified sensitivity analyses and a timing-restricted continuous-score sensitivity model were additionally performed. Results: Prior psychiatric diagnosis was recorded in 16.0% of women, post-MI psychiatric diagnosis in 31.4%, and any psychosocial stressor in 73.2%. Among women with complete item responses, the four-item summary showed a broad distribution rather than a discrete threshold pattern. In continuous-score analyses, higher observed summary values were associated with younger age, prior psychiatric diagnosis, any psychosocial stressor, non-partnered status, non-employment, pregnancy complications/adverse pregnancy outcomes, and greater peri-menopausal symptom burden. Median summary values were only modestly higher in the small ≤ 1-year stratum and were otherwise similar across the later follow-up strata. Higher summary values were also associated with lower odds of self-reported regular current statin-based lipid-lowering use. Conclusions: These findings are best interpreted as exploratory data on retrospectively reported and currently endorsed long-term psychological and psychosocial burden years after MI, not as contemporaneous measures of recovery-phase psychopathology. Prospective studies with predefined assessment windows and validated instruments are needed.

1 January 2021 in Cardiologia Croatica
Verified
Journal Article
Closed access
IJIvana Jurin
Ivana Jurin
MLMarko Lucijanic
Marko Lucijanic
VRVedran Radonić
Vedran Radonić
TLTomislav Letilović
Tomislav Letilović
DRDiana Rudan
Diana Rudan
IHIrzal Hadžibegović
Irzal Hadžibegović

1 November 2016 in Cardiologia Croatica
Verified
Journal Article
Closed access
VRVedran Radonić
Vedran Radonić
HJHrvoje Jurin
Hrvoje Jurin
MGMarijana Grgić
Marijana Grgić
MEMedić
Medić

1 January 2021 in Cardiologia Croatica
Verified
Journal Article
Closed access
IJIvana Jurin
Ivana Jurin
MLMarko Lucijanic
Marko Lucijanic
VRVedran Radonić
Vedran Radonić
TLTomislav Letilović
Tomislav Letilović
JĆJasmina Ćatić
Jasmina Ćatić
IHIrzal Hadžibegović
Irzal Hadžibegović